S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
NASDAQ:NEOG

Neogen (NEOG) Stock Forecast, Price & News

$26.89
+0.94 (+3.62%)
(As of 05/17/2022 04:00 PM ET)
Add
Compare
Today's Range
$25.96
$26.92
50-Day Range
$25.08
$35.35
52-Week Range
$24.90
$47.80
Volume
636,576 shs
Average Volume
508,234 shs
Market Capitalization
$2.90 billion
P/E Ratio
58.46
Dividend Yield
N/A
Beta
0.6
30 days | 90 days | 365 days | Advanced Chart
Receive NEOG News and Ratings via Email

Sign-up to receive the latest news and ratings for Neogen and its competitors with MarketBeat's FREE daily newsletter.

Neogen logo

About Neogen

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Headlines

NEOGEN Genomics Earns CLIA Certificate of Compliance
Neogen (NASDAQ:NEOG) Shares Gap Down to $29.50
Neogen Corp. (NEOG) Names COO - StreetInsider.com
See More Headlines

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:NEOG
CUSIP
64049110
Employees
1,841
Year Founded
1982

Sales & Book Value

Annual Sales
$468.46 million
Cash Flow
$0.78 per share
Book Value
$7.85 per share

Profitability

Net Income
$60.88 million
Pretax Margin
11.94%

Debt

Price-To-Earnings

Miscellaneous

Free Float
107,257,000
Market Cap
$2.90 billion
Optionable
Optionable

Company Calendar

Last Earnings
3/24/2022
Today
5/17/2022
Fiscal Year End
5/31/2022
Next Earnings (Estimated)
7/19/2022

Social Links


MarketRank

Overall MarketRank

1.38 out of 5 stars

Medical Sector

1097th out of 1,426 stocks

Diagnostic Substances Industry

16th out of 27 stocks

Analyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -













Neogen (NASDAQ:NEOG) Frequently Asked Questions

When is Neogen's next earnings date?

Neogen is scheduled to release its next quarterly earnings announcement on Tuesday, July 19th 2022.
View our earnings forecast for Neogen
.

How were Neogen's earnings last quarter?

Neogen Co. (NASDAQ:NEOG) issued its earnings results on Thursday, March, 24th. The company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.15 by $0.02. The firm earned $128.40 million during the quarter, compared to analysts' expectations of $129.99 million. Neogen had a trailing twelve-month return on equity of 7.51% and a net margin of 9.55%. The firm's quarterly revenue was up 10.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.13 earnings per share.
View Neogen's earnings history
.

When did Neogen's stock split? How did Neogen's stock split work?

Shares of Neogen split on Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly issued shares were payable to shareholders after the closing bell on Friday, December 29th 2017. An investor that had 100 shares of Neogen stock prior to the split would have 133 shares after the split.

Who are Neogen's key executives?
Neogen's management team includes the following people:
  • Mr. John Edward Adent, Pres, CEO & Director (Age 54, Pay $844.43k)
  • Mr. Steven J. Quinlan, VP & CFO (Age 60, Pay $381.33k) (LinkedIn Profile)
  • Mr. Douglas E. Jones, COO, VP & Chief Commercial Officer (Age 51, Pay $474.62k)
  • Sarah Demey, Admin. Mang.
  • Ms. Amy M. Rocklin Ph.D., VP, Gen. Counsel & Corp. Sec. (Age 50)
  • Ms. Julie A. Mann, VP & Chief HR Officer (Age 57)
What is John Adent's approval rating as Neogen's CEO?

31 employees have rated Neogen CEO John Adent on Glassdoor.com. John Adent has an approval rating of 56% among Neogen's employees. This puts John Adent in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Neogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neogen investors own include NVIDIA (NVDA), NIKE (NKE), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Boeing (BA), JPMorgan Chase & Co. (JPM), W. P. Carey (WPC), Advanced Micro Devices (AMD) and Costco Wholesale (COST).

What is Neogen's stock symbol?

Neogen trades on the NASDAQ under the ticker symbol "NEOG."

Who are Neogen's major shareholders?

Neogen's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (10.85%), Vanguard Group Inc. (9.71%), Wasatch Advisors Inc. (6.29%), Select Equity Group L.P. (3.77%), Conestoga Capital Advisors LLC (3.59%) and State Street Corp (3.33%). Company insiders that own Neogen stock include Bruce Papesh, Douglas Edward Jones, James L Herbert, James P Tobin, Jason Warren Lilly, John Edward Adent, Steven J Quinlan, Terri A Morrical and William T Boehm.
View institutional ownership trends for Neogen
.

Which major investors are selling Neogen stock?

NEOG stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., Wasatch Advisors Inc., Vanguard Group Inc., Prudential Financial Inc., Northern Trust Corp, UBS Group AG, Citigroup Inc., and New York State Common Retirement Fund. Company insiders that have sold Neogen company stock in the last year include Jason Warren Lilly, Steven J Quinlan, and William T Boehm.
View insider buying and selling activity for Neogen
or view top insider-selling stocks.

Which major investors are buying Neogen stock?

NEOG stock was bought by a variety of institutional investors in the last quarter, including Select Equity Group L.P., Goldman Sachs Group Inc., JPMorgan Chase & Co., Congress Asset Management Co. MA, Renaissance Technologies LLC, State Street Corp, Conestoga Capital Advisors LLC, and Riverbridge Partners LLC. Company insiders that have bought Neogen stock in the last two years include Douglas Edward Jones, and James P Tobin.
View insider buying and selling activity for Neogen
or or view top insider-buying stocks.

How do I buy shares of Neogen?

Shares of NEOG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Neogen's stock price today?

One share of NEOG stock can currently be purchased for approximately $26.89.

How much money does Neogen make?

Neogen has a market capitalization of $2.90 billion and generates $468.46 million in revenue each year. The company earns $60.88 million in net income (profit) each year or $0.46 on an earnings per share basis.

How many employees does Neogen have?

Neogen employs 1,841 workers across the globe.

When was Neogen founded?

Neogen was founded in 1982.

What is Neogen's official website?

The official website for Neogen is www.neogen.com.

How can I contact Neogen?

Neogen's mailing address is 620 LESHER PLACE, LANSING MI, 48912. The company can be reached via phone at (517) 372-9200, via email at [email protected], or via fax at 517-372-2006.

This page was last updated on 5/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.